CarfìA, BernabeiR, LandiF. Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA, 2020; 324(6):603-605.
2.
MorinL, SavaleL, PhamT, ColleR, FigueiredoS, HarroisA, et al. Writing Committee for the COMEBAC Study Group. Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA, 2021; 325(15):1525-1534.
3.
BellanM, SodduD, BalboPE, BaricichA, ZeppegnoP, AvanziGC, et al. Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw Open, 2021; 4(1):e2036142.
4.
GulerSA, EbnerL, Aubry-BeigelmanC, BridevauxPO, BrutscheM, ClarenbachC, et al. Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur Respir J, 2021; 57(4):2003690.
5.
HuangC, HuangL, WangY, LiX, RenL, GuX, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet, 2021; 397(10270):220-232.
6.
WuX, LiuX, ZhouY, YuH, LiR, ZhanQ, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19–related hospitalization: a prospective study. Lancet Respir Med, 2021; 9(7):747-754.
7.
VitaccaM, PaneroniM, BrunettiG, et al. Physiological and symptom characteristics of survivors of COVID-19–associated pneumonia, with resting normoxemia and exercise-induced desaturation. Respir Care, 2021; 66(11):1657-1664.
8.
ArnoldDT, HamiltonFW, MilneA, MorleyAJ, VinerJ, AttwoodM, et al. Patient outcomes after hospitalization with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax, 2021; 76(4):399-401.
9.
AhmedH, PatelK, GreenwoodDC, HalpinS, LewthwaiteP, SalawuA, et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalization or ICU admission: a systematic review and meta-analysis. J Rehabil Med, 2020; 52(5):jrm00063.
10.
ManningHL, SchwartzsteinRM. Pathophysiology of dyspnea. N Engl J Med, 1995; 333(23):1547-1553.
11.
HollandAE. Review series: aspects of interstitial lung disease: exercise limitation in interstitial lung disease - mechanisms, significance, and therapeutic options. Chron Respir Dis, 2010; 7(2):101-111.
12.
O'DonnellDE, HamiltonAL, WebbKA. Sensory-mechanical relationships during high-intensity, constant work-rate exercise in COPD. J Appl Physiol (1985), 2006; 101(4):1025-1035.
13.
FaisalA, AlghamdiBJ, CiavagliaCE, ElbehairyAF, WebbKA, OraJ, et al. Common mechanisms of dyspnea in chronic interstitial and obstructive lung disorders. Am J Respir Crit Care Med, 2016; 193(3):299-309.
14.
PotusF, MaiV, LebretM, MalenfantS, Breton-GagnonE, LajoieAC, et al. Novel insights on the pulmonary vascular consequences of COVID-19. Am J Physiol Lung Cell Mol Physiol, 2020; 319(2):L277-L88.
15.
RinaldoRF, MondoniM, ParazziniEM, PitariF, BrambillaE, LuraschiS, et al. Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors. Eur Respir J, 2021; 58(2):2100870.
16.
MotiejunaiteJ, BalagnyP, ArnoultF, ManginL, BancalC, Vidal-PetiotE, et al. Hyperventilation as one of the mechanisms of persistent dyspnea in SARS-CoV-2 survivors. Eur Respir J, 2021; 58(2):2101578.
17.
Cortés-TellesA, López-RomeroS, Figueroa-HurtadoE, Pou-AguilarYN, WongAW, MilneKM, et al. Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnea. Respir Physiol Neurobiol, 2021; 288:103644.
18.
MahlerDA, HarverA, LentineT, ScottJA, BeckK, SchwartzsteinRM. Descriptors of breathlessness in cardiorespiratory diseases. Am J Respir Crit Care Med, 1996; 154(5):1357-1363.
19.
ManningHL, MolinaryEJ, LeiterJC. Effect of inspiratory flow rate on respiratory sensation and pattern of breathing. Am J Respir Crit Care Med, 1995; 151(3):751-757.
20.
KoryP, KanneJP. SARS-CoV-2 organizing pneumonia: “Has there been a widespread failure to identify and treat this prevalent condition in COVID-19?”. BMJ Open Resp Res, 2020; 7(1):e000724.
